Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,897 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Proposed quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using the veterinary antimicrobial agent tiamulin.
Pfaller MA, Jones RN, Walter DH; Quality Control Study Group. Pfaller MA, et al. Among authors: jones rn. Diagn Microbiol Infect Dis. 2001 May-Jun;40(1-2):67-70. doi: 10.1016/s0732-8893(01)00239-5. Diagn Microbiol Infect Dis. 2001. PMID: 11448566
Assessment of 30/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa.
Sader HS, Rhomberg PR, Huband MD, Critchley IA, Stone GG, Flamm RK, Jones RN. Sader HS, et al. Among authors: jones rn. J Clin Microbiol. 2018 May 25;56(6):e01960-17. doi: 10.1128/JCM.01960-17. Print 2018 Jun. J Clin Microbiol. 2018. PMID: 29563198 Free PMC article.
Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014.
Pfaller MA, Flamm RK, Jones RN, Farrell DJ, Mendes RE. Pfaller MA, et al. Among authors: jones rn. Antimicrob Agents Chemother. 2016 Aug 22;60(9):5393-9. doi: 10.1128/AAC.00881-16. Print 2016 Sep. Antimicrob Agents Chemother. 2016. PMID: 27353270 Free PMC article.
Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.
Sader HS, Farrell DJ, Flamm RK, Jones RN. Sader HS, et al. Among authors: jones rn. Surg Infect (Larchmt). 2016 Aug;17(4):443-7. doi: 10.1089/sur.2015.209. Epub 2016 Mar 18. Surg Infect (Larchmt). 2016. PMID: 26990170
Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014.
Sader HS, Flamm RK, Mendes RE, Farrell DJ, Jones RN. Sader HS, et al. Among authors: jones rn. Antimicrob Agents Chemother. 2016 Mar 25;60(4):2558-63. doi: 10.1128/AAC.02794-15. Print 2016 Apr. Antimicrob Agents Chemother. 2016. PMID: 26856825 Free PMC article.
Analysis of Vancomycin Susceptibility Testing Results for Presumptive Categorization of Telavancin.
Mendes RE, Farrell DJ, Flamm RK, Sader HS, Jones RN. Mendes RE, et al. Among authors: jones rn. J Clin Microbiol. 2015 Aug;53(8):2727-30. doi: 10.1128/JCM.00611-15. Epub 2015 May 27. J Clin Microbiol. 2015. PMID: 26019194 Free PMC article.
Validation of a commercial dry-form broth microdilution device (Sensititre) for testing tedizolid, a new oxazolidinone.
Jones RN, Holliday NM, Rhomberg PR. Jones RN, et al. J Clin Microbiol. 2015 Feb;53(2):657-9. doi: 10.1128/JCM.02769-14. Epub 2014 Nov 19. J Clin Microbiol. 2015. PMID: 25411167 Free PMC article.
In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.
Pfaller MA, Messer SA, Rhomberg PR, Jones RN, Castanheira M. Pfaller MA, et al. Among authors: jones rn. J Clin Microbiol. 2013 Aug;51(8):2608-16. doi: 10.1128/JCM.00863-13. Epub 2013 Jun 5. J Clin Microbiol. 2013. PMID: 23740727 Free PMC article.
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M. Pfaller MA, et al. Among authors: jones rn. J Clin Microbiol. 2013 Aug;51(8):2571-81. doi: 10.1128/JCM.00308-13. Epub 2013 May 29. J Clin Microbiol. 2013. PMID: 23720791 Free PMC article.
More potency assay results for generic non-USA lots of piperacillin/tazobactam and initial reports for generic meropenem compounds marketed in the USA.
Jones RN, Sader HS, Flamm RK, Watters AA. Jones RN, et al. Diagn Microbiol Infect Dis. 2013 May;76(1):110-2. doi: 10.1016/j.diagmicrobio.2013.01.024. Epub 2013 Mar 13. Diagn Microbiol Infect Dis. 2013. PMID: 23490010
1,897 results
Jump to page
Feedback